论文部分内容阅读
Monoclonal antibody based biotherapeutics,the one of great achievements of modern biotechnology,has played an active role and also succeed in treating various life threatening and chronic diseases including cancer,autoimmunity,transplantation and infectious diseases etc.Global market share and R&D of these products in China increased rapidly in recently.